Factors affecting Antiepileptic Drug Pharmacokinetics in Community-Dwelling Elderly

International Review of Neurobiology

Volumn 81, Issue , 2007, Pages 201-210

  Cloyd, James C ^a   Marino, Susan ^b   Birnbaum, Angela K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN;

ABSORPTION; ADULT; AGED; AGING; BIOAVAILABILITY; BLOOD; FEMALE; HALF LIFE TIME; HUMAN; MALE; METABOLISM; MIDDLE AGED; REVIEW;

ABSORPTION; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTICONVULSANTS; BIOLOGICAL AVAILABILITY; CARBAMAZEPINE; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN;

EID: 34047239775     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(06)81012-3     Document Type: Review

References (18)

1. Battino D., Croci D., Rossini A., Messina S., Mamoli D., and Perucca E. Serum carbamazepine concentrations in elderly patients: A case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44 (2003) 923-929
2. Bauer L.A., and Blouin R.A. Age and phenytoin kinetics in adult epileptics. Clin. Pharmacol. Ther. 31 (1982) 301-304
3. Brodie M.J., and Kwan P. Epilepsy in elderly people. BMJ 331 (2005) 1317-1322
4. Cloyd J.C., and Conway J.M. Age-related changes in pharmacokinetics, drug interactions, and adverse effects. In: Sirven J.I., and Malamut B.L. (Eds). "Clinical Neurology of the Older Adult" (2002), Lippincott Williams & Wilkins, Philadelphia 29-44
5. Cloyd J.C., Sawchuk R.J., Leppik I.E., and Pepin S.M. The direct linear plot: Use in estimating Michaelis-Menten parameters and individualizing phenytoin dosage regimens in epileptic patients. Presented at: (1978), Epilepsy International Symposium, Vancouver, Canada
6. Conway J.M., and Cloyd J.C. Antiepileptic drug interactions in the elderly. In: Majkowski J., Bourgeois B.F.D., Patsalos P.N., and Mattson R.H. (Eds). "Antiepileptic Drugs: Combination Therapy and Interactions". 1st ed. (2005), Cambridge University Press, Cambridge 273-293
7. Gidal B.E., Garnett W.R., and Graves N. Epilepsy. In: DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., and Posey L.M. (Eds). "Pharmacotherapy: A Pathophysiologic Approach". 5th ed. (2002), McGraw-Hill, New York 1031-1059
8. Graves N.M., Brundage R.C., Wen Y., Cascino G., So E., Ahman P., Rarick J., Krause S., and Leppik I.E. Population pharmacokinetics of carbamazepine in adults with epilepsy. Pharmacotherapy 18 (1998) 273-281
9. Lackner T.E., Cloyd J.C., Thomas L.W., and Leppik I.E. Antiepileptic drug use in nursing home residents: Effect of age, gender, and comedication on patterns of use. Epilepsia 39 (1998) 1083-1087
10. Leppik I.E., and Cloyd J.C. General principles: Epilepsy in the elderly. In: Levy R.H., Mattson R.H., Meldrum B.S., and Perucca E. (Eds). "Antiepileptic Drugs". 5th ed. (2002), Lippincott Williams & Wilkins, Philadelphia 149-158
11. Nitz N.M., Garrard J., Harms S.L., Hardie N.A., Bland P.C., Gross C.R., and Leppik I.E. Prevalence of antiepileptic drug use among Medicare beneficiaries [abstract]. Epilepsia 41 Suppl. 7 (2000) 251
12. Perucca E., Berlowitz D., Birnbaum A., Cloyd J.C., Garrard J., Hanlon J.T., Levy R.H., and Pugh M.J. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 68 Suppl. 1 (2006) S49-S63
13. Pfizer Inc. Dilantin (phenytoin) package insert (2003), Pfizer Inc., New York, NY
14. Ramsay R.E., Rowan A.J., Slater J.D., Collins J., Nemire R., Ortiz W.R., and the VA Cooperative Study Group. Effect of age on epilepsy and its treatment: Results from the VA Cooperative Study [abstract]. Epilepsia 35 (1994) 91
15. Rowan A.J., Ramsay R.E., Collins J.F., Pryor F., Boardman K.D., Uthman B.M., Spitz M., Frederick T., Towne A., Carter G.S., Marks W., Felicetta J., et al. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 (2005) 1868-1873
16. Spina E. Carbamazepine: Chemistry, biotransformation, and pharmacokinetics. In: Levy R.H., Mattson R.H., Meldrum B.S., and Perucca E. (Eds). "Antiepileptic Drugs". 5th ed. (2002), Lippincott Williams & Wilkins, Philadelphia 236-246
17. Stephen L.J., Kelly K., Mohanraj R., and Brodie M.J. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav. 8 (2006) 434-437
18. Woo J., Chan H.S., Or K.H., and Arumanayagam M. Effect of age and disease on two drug binding proteins: Albumin and alpha-1-acid glycoprotein. Clin. Biochem. 27 (1994) 289-292